Press

For Immediate Release

 

Media Contacts:
Dawn Peters (US) +1 781-388-8408
Ben Norman (UK) +44 (0) 1243 770375
sciencenewsroom@wiley.com

 

Are Living Liver Donors at Risk from Life-threatening “Near-miss” Events?

 

A study published in the March issue of Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, reports that donor mortality is about 1 in 500 donors with living donor liver transplantation (LDLT).  Research of transplant centers around the world found that those with more experience conducting live donor procedures had lower rates of aborted surgery and life-threatening “near miss” events.

For patients with end-stage liver disease, liver transplantation is their only option to prolong life.  However, more than 16,000 Americans are currently on the waiting list for a liver according to the Organ Procurement and Transplantation Network (OPTN).  The critical shortage of deceased donor organs has increased LDLT—a procedure that uses a healthy portion of the liver from a living donor for transplant.  Although prior research shows that LDLT is an effective treatment, a 2007 study by de Villa et al. found that LDLT accounts for less than five percent of liver transplants in the U.S. and Europe.

“Donors who decide to provide a portion of their liver to a family member in need are making an extremely difficult decision to save the life of a loved one,” explains lead author Dr. Elizabeth Pomfret, Professor of Surgery at Tufts University and Chair of the Department of Transplantation and Hepatobiliary Diseases at Lahey Hospital & Medical Center in Burlington, Mass. “It is our responsibility as transplant specialists to provide donors with comprehensive information and education relating to LDLT, including any risks, so they may make informed decisions about donation.”

To extend understanding of potential risks for liver lobe donors, the team conducted a web-based survey of 148 transplant centers around the world that perform LDLTs.  Center representatives were asked to provide donor demographics; morbidity and mortality incidence; “near-miss” event data, and number of aborted procedures.  Potentially life-threatening “near-miss” events included severe intraoperative bleeding, reoperation for bleeding, biliary reconstruction and pulmonary embolism.

A total of 71 centers (48%) responded to the survey, representing 21 countries, and performing 11,553 LDLTs procedures. Analysis shows that donor morbidity was 24% including five donors who required liver transplantation.  Donor mortality was 0.2% (23/11,553), with the majority of deaths occurring within 60 days post-transplant and 19 deaths were a direct result of transplant surgery.  Researchers reported that “near-miss” event and aborted surgery incidence was 1.1% and 1.2%, respectively.

Dr. Pomfret concludes, “It appears that the 0.2% donor mortality rate was consistent and independent of the center’s experience performing LDLTs. However, increased experience—centers performing more than 50 total LDLTs is associated with lower rates of aborted procedures and “near miss” events. These potentially life-threatening complications must be discussed as part of the informed consent with any potential liver donor.”

In a related editorial, Dr. Daniela Ladner, Assistant Professor of Surgery at Northwestern University Feinberg School of Medicine in Chicago, IL agrees, “Living liver donation is arguably the most invasive operation we as surgeons perform in willing patients with no demonstrable medical benefit, allowing them to donate a portion of their liver to save the life of someone with end-stage liver disease.  As Dr. Pomfret and colleagues suggest, transplant surgeons are obligated to fully disclose all potential risk to donors.”  Dr. Ladner also suggests that all complications as well as near miss events that did not reach the patient should be captured and systematically examined to identify areas of improvement with LDLT procedures and reduce life-threatening events for living donors.

This study and editorial are published in Liver Transplantation. Media wishing to receive a PDF of the articles may contact sciencenewsroom@wiley.com.

Full Citations: “The Incidence of Death and Potentially Life-Threatening “Near Miss” Events in Living Donor Hepatic Lobectomy: A World-Wide Survey.”  Yee Lee Cheah, Mary Ann Simpson, James J. Pomposelli, Elizabeth A. Pomfret.  Liver Transplantation; (DOI: 10.1002/lt.23575) Print Issue Date: March, 2013.

http://onlinelibrary.wiley.com/doi/10.1002/lt.23575/abstract

Editorial: “Near Miss Events–A Vastly Missed Opportunity.”  Daniela P Ladner and Talia Baker.  Liver Transplantation; (DOI: 10.1002/lt.XXXX) Print Issue Date: March, 2013. http://onlinelibrary.wiley.com/doi/10.1002/lt.XXXX/abstract

Author Contact: Media wishing to speak with Dr. Pomfret may contact Christine Kenney at Lahey Hospital & Medical Center at Christine.R.Kenney@Lahey.org or 781-744-3922.  To speak with Dr. Ladner, please contact Marla Paul with Northwestern University Feinberg School of Medicine at marla-paul@northwestern.edu or  312-503-8928.

About the Journal

Liver Transplantation is published on behalf of The American Association for the Study of Liver Diseases and the International Liver Transplantation Society. Since the first application of liver transplantation in a clinical situation was reported more than twenty years ago, there has been a great deal of growth in this field and more is anticipated. As an official publication of the AASLD and the ILTS, Liver Transplantation delivers current, peer-reviewed articles on surgical techniques, clinical investigations and drug research — the information necessary to keep abreast of this evolving specialty. For more information, please visit http://onlinelibrary.wiley.com/journal/lt.

 

About Wiley
Wiley is a global provider of content-enabled solutions that improve outcomes in research, education, and professional practice. Our core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners.

Founded in 1807, John Wiley & Sons, Inc. (NYSE: JWa, JWb), has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace. Wiley’s global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company’s website can be accessed at http://www.wiley.com.

Media Advisory

What: The 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)

Founded in 1950, AASLD is the leading organization of scientists and healthcare professionals committed to preventing and curing liver disease. AASLD has grown into an international society responsible for all aspects of hepatology, and the annual meeting attracts 8,500 physicians, surgeons, researchers, and allied health professionals from around the world.

The Liver Meeting® is the premier meeting in the science and practice of hepatology, including the latest findings on new drugs, novel treatments, and the results from pilot and multicenter studies.

When: November 9-13, 2012

Where:

Hynes Convention Center

Boston, Massachusetts

Contact: Please click here to obtain a press pass for this event.

 

 

This page last updated: March 13, 2014 at 5:52 pm